IKS IPO: A Long-Term Investment Opportunity with Strong Growth PotentialDefault Banner

IKS IPO: A Long-Term Investment Opportunity with Strong Growth Potential

Writer
TEAM
Status
Online
Timer
December 17, 2024

Swastika Investmart recommends investors consider subscribing to the IPO for the long term, citing the company's robust financial performance, growth, and improving profit margins. The firm emphasizes that IKS is a prominent partner in outpatient and inpatient care, with no comparable listed peers.

  • International Gemmological Institute IPO subscribed 72% on Day 2. Check GMP, other details
    The Economic Times
  • Final Hours! IKS IPO closes today: Subscription zooms 4x, GMP up 30%
    Business Standard
  • IGI IPO closes today: Check subscription status, GMP, and listing schedule
    Business Standard
  • Inventurus Knowledge Solutions IPO Day 3 Live Updates: Issue subscribed 52.68x, check IKS IPO GMP, review, more
    Mint
  • International Gemmological Institute IPO day 2: GMP, subscription status to review. Apply or not?
    Mint
  • International Gemmological Institute IPO Day 3: GMP, subscription status, review & other details. Apply or not?
    Mint

    • ‍

    No items found.
    Follow us on social media:
    Thank you! Your submission has been received!
    Oops! Something went wrong while submitting the form.